Two cases with bullous pemphigoid relapsed after using interleukin‐17A inhibitors for psoriasis: A paradoxical reaction
The Journal of Dermatology · 2023
DOI: 10.1111/1346-8138.16765 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Journal of Dermatology, 2023. Verfasst von Rui Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Pemphigoid, Bullous, Psoriasis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Biological drugs, including IL‐17A inhibitors, have become the first‐line treating options for moderate to severe psoriasis, and reports show a beneficial effect of IL‐17A inhibitors on bullous pemphigoid. Here, we report two cases of bullous pemphigoid in remission that experienced severe flares during treatment with two major IL‐17A inhibitors, i.e., ixekizumab or secukinumab for their psoriasis vulgaris. The patient with bullous pemphigoid induced by secukinumab became very recalcitrant to control the relapse. This is by far the first and paradoxical report on the IL‐17A inhibitors having a negative effect on bullous pemphigoid patients in previously stable status. Our reports of these two cases alert clinicians to be careful when using IL‐17A in pemphigoid patients. We also suggest that patients with psoriasis vulgaris should be asked for a detailed history of pemphigoid and its BP180 autoantibodies status be checked before using these biologicals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Peking University First Hospital, Beijing, China.
- National Clinical Research Center for Skin and Immune Diseases, Beijing, China.
- Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China.
- NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China.
ORCID-Profile: Mingyue Wang
Zitieren
APA
Wang, R., Wang, A., & Wang, M. (2023). Two cases with bullous pemphigoid relapsed after using interleukin‐17A inhibitors for psoriasis: A paradoxical reaction. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.16765
Vancouver
Wang R, Wang A, Wang M. Two cases with bullous pemphigoid relapsed after using interleukin‐17A inhibitors for psoriasis: A paradoxical reaction. The Journal of Dermatology. 2023. doi:10.1111/1346-8138.16765
BibTeX
@article{Wang2023,
author = {Wang, Rui and Wang, Aiping and Wang, Mingyue},
title = {Two cases with bullous pemphigoid relapsed after using interleukin‐17A inhibitors for psoriasis: A paradoxical reaction},
journal = {The Journal of Dermatology},
year = {2023},
doi = {10.1111/1346-8138.16765}
}
EUVIMED